Preparando la implementación de nuevas vacunas en el embarazo: Estudio de las barreras y facilitadores de la aceptabilidad de vacunas en embarazadas

Resumen del proyecto

Maternal immunization is an excellent evidence-based approach for preventing severe disease and decreasing neonatal and infant deaths. Tetanus, pertussis and influenza vaccines are recommended for pregnant women globally, however, despite the proven benefits and availability of safe and effective vaccines, as well as the recommendations by the World Health Organization, coverage among pregnant women remains sub-optimal. New maternal vaccines against respiratory syncytial virus (RSV) and Group B Streptococcus (GBS) will be available in the upcoming years. Understanding baseline awareness and perceived risk and benefits of maternal immunization among pregnant women and health care providers is essential to better anticipate acceptance of new maternal immunization strategies. This study aims to advance in the understanding of potential barriers and facilitators to maternal vaccine acceptance in preparation for wide implementation and uptake of future vaccines in pregnancy. In order to address this, we propose to conduct a mixed-methods research study on the drivers that influence maternal vaccine acceptance among pregnant women and health care providers. This study is expected to provide the information needed to guide decisions and approaches for effective implementation of future maternal vaccines.

Palabras clave

Salud materna
vacunas
aceptabilidad
determinantes

Convocatoria

Acción Estratégica en Salud (AES)

Periodo de ejecución

01/01/2020 - 31/12/2022

Investigador Principal

BARDAJI ALONSO, AZUCENA

Centro beneficiario

FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA (ISGLOBAL)

Centro de realización

HOSPITAL CLINICO Y PROVINCIAL DE BARCELONA

Comunidad Autónoma

CATALUÑA

Provincia

BARCELONA

Financiación

62,920 €